精神心理指南

订阅

MedSci主页 / 所有栏目 / 精神心理指南

2019 APA临床实践指南：跨越3个年龄组的抑郁症治疗（概要）

2021-11-29 美国精神病学会 Am Psychol

抑郁症抑郁障碍

美国精神病学会(APA)跨越3个年龄组的抑郁症治疗指南，提供了抑郁症的治疗建议，涉及抑郁症、亚综合征性抑郁和持续性抑郁症。本文为指南的概要内容。

中文标题：

2019 APA临床实践指南：跨越3个年龄组的抑郁症治疗（概要）

英文标题：

Summary of the clinical practice guideline for the treatment of depression across three age cohorts

发布机构：

美国精神病学会

发布日期：

2021-11-29

简要介绍：

美国精神病学会(APA)跨越3个年龄组的抑郁症治疗指南，提供了抑郁症的治疗建议，涉及抑郁症、亚综合征性抑郁和持续性抑郁症。本文为指南的概要内容。

暂无翻译

相关资料下载：
[AttachmentFileName(sort=1, fileName=2019 APA临床实践指南：跨越3个年龄组的抑郁症治疗（概要）.pdf)] GetToolGuiderByIdResponse(projectId=1, id=76acd1c002281ec9, title=2019 APA临床实践指南：跨越3个年龄组的抑郁症治疗（概要）, enTitle=Summary of the clinical practice guideline for the treatment of depression across three age cohorts, guiderFrom=Am Psychol, authorId=0, author=, summary=美国精神病学会(APA)跨越3个年龄组的抑郁症治疗指南，提供了抑郁症的治疗建议，涉及抑郁症、亚综合征性抑郁和持续性抑郁症。本文为指南的概要内容。, cover=https://img.medsci.cn/2021122/1638453892822_1608702.jpg, journalId=0, articlesId=null, associationId=33, associationName=美国精神病学会, associationIntro=美国精神病学协会，成立于1844年，是世界上最大的精神病届的组织。它是一个来自美国和世界各地的36000名精神科医生的医疗专业团体。其会员医生们一起工作，以确保人文关怀和有效的治疗所有精神障碍患者，包括智力发育障碍和物质使用障碍。APA是现代精神病学中的发言权和良知。APA成员的主要医疗专家是由精神科医生或在这个过程中逐渐成为精神科医生的。 APA有美国精神病学基金会（APF）、美国精神病学出版社（APP）、美国精神病学研究所的研究和教育（APIRE）3个部门。 美国精神病学会1991年开始建立指南，实践指南提供基于证据的精神疾病的评估和治疗建议，该学会指南专门为成人制定，关于儿童和青少年的精神疾病的治疗，指南，是由美国儿童和青少年精神病学制定。, copyright=0, guiderPublishedTime=Mon Nov 29 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>美国精神病学会(APA)跨越3个年龄组的抑郁症治疗指南，提供了抑郁症的治疗建议，涉及抑郁症、亚综合征性抑郁和持续性抑郁症。本文为指南的概要内容。</p> </div> </div> </div> <div class="box_info" style="color: #373737;"> <div class="box_info_list"> <div class="one_info3 clearfix"> <p class="inner_label" style="color: #ffffff;"><label class="translate">翻译：</label></p> <div class="inner_info_list"> <div class="one_inner_info" style="color: #999999;"> <p class="no_translate" style="color: #333333;">暂无翻译</p> </div> </div> </div> </div> </div>, tagList=[TagDto(tagId=228, tagName=抑郁症), TagDto(tagId=20577, tagName=抑郁障碍)], categoryList=[CategoryDto(categoryId=13, categoryName=精神心理, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=228, guiderKeyword=抑郁症, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=1, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=3475, appHits=118, showAppHits=0, pcHits=1049, showPcHits=3356, likes=0, shares=7, comments=9, approvalStatus=1, publishedTime=Thu Dec 02 22:19:14 CST 2021, publishedTimeString=2021-11-29, pcVisible=1, appVisible=1, editorId=1608702, editor=dajiong, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=dajiong, createdTime=Thu Dec 02 22:08:59 CST 2021, updatedBy=1608702, updatedName=dajiong, updatedTime=Fri Jan 05 23:37:13 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2019 APA临床实践指南：跨越3个年龄组的抑郁症治疗（概要）.pdf)])
2019 APA临床实践指南：跨越3个年龄组的抑郁症治疗（概要）.pdf
下载请点击：
评论区 (8)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2099581, encodeId=1c44209958151, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210420/09716af288084795ba128059da55a818/c3137a18601c4c54bb7d71ac97630870.jpg, createdBy=e9985480565, createdName=ozzy, createdTime=Thu Nov 10 11:21:43 CST 2022, time=2022-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083364, encodeId=ccca108336459, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d25a5516768, createdName=一己怀, createdTime=Wed Dec 22 23:56:19 CST 2021, time=2021-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083363, encodeId=d093108336353, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d25a5516768, createdName=一己怀, createdTime=Wed Dec 22 23:56:17 CST 2021, time=2021-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079886, encodeId=77e310e988655, content=学习了，翻译一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=283c6401883, createdName=ms7000001380639524, createdTime=Tue Dec 14 10:46:57 CST 2021, time=2021-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077143, encodeId=073e10e714306, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=454b5463066, createdName=魏一, createdTime=Sun Dec 05 20:50:16 CST 2021, time=2021-12-05, status=1, ipAttribution=)]
    2022-11-10 ozzy

    谢谢分享

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2099581, encodeId=1c44209958151, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210420/09716af288084795ba128059da55a818/c3137a18601c4c54bb7d71ac97630870.jpg, createdBy=e9985480565, createdName=ozzy, createdTime=Thu Nov 10 11:21:43 CST 2022, time=2022-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083364, encodeId=ccca108336459, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d25a5516768, createdName=一己怀, createdTime=Wed Dec 22 23:56:19 CST 2021, time=2021-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083363, encodeId=d093108336353, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d25a5516768, createdName=一己怀, createdTime=Wed Dec 22 23:56:17 CST 2021, time=2021-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079886, encodeId=77e310e988655, content=学习了，翻译一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=283c6401883, createdName=ms7000001380639524, createdTime=Tue Dec 14 10:46:57 CST 2021, time=2021-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077143, encodeId=073e10e714306, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=454b5463066, createdName=魏一, createdTime=Sun Dec 05 20:50:16 CST 2021, time=2021-12-05, status=1, ipAttribution=)]
    2021-12-22 一己怀

    谢谢分享

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2099581, encodeId=1c44209958151, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210420/09716af288084795ba128059da55a818/c3137a18601c4c54bb7d71ac97630870.jpg, createdBy=e9985480565, createdName=ozzy, createdTime=Thu Nov 10 11:21:43 CST 2022, time=2022-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083364, encodeId=ccca108336459, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d25a5516768, createdName=一己怀, createdTime=Wed Dec 22 23:56:19 CST 2021, time=2021-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083363, encodeId=d093108336353, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d25a5516768, createdName=一己怀, createdTime=Wed Dec 22 23:56:17 CST 2021, time=2021-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079886, encodeId=77e310e988655, content=学习了，翻译一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=283c6401883, createdName=ms7000001380639524, createdTime=Tue Dec 14 10:46:57 CST 2021, time=2021-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077143, encodeId=073e10e714306, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=454b5463066, createdName=魏一, createdTime=Sun Dec 05 20:50:16 CST 2021, time=2021-12-05, status=1, ipAttribution=)]
    2021-12-22 一己怀

    谢谢分享

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2099581, encodeId=1c44209958151, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210420/09716af288084795ba128059da55a818/c3137a18601c4c54bb7d71ac97630870.jpg, createdBy=e9985480565, createdName=ozzy, createdTime=Thu Nov 10 11:21:43 CST 2022, time=2022-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083364, encodeId=ccca108336459, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d25a5516768, createdName=一己怀, createdTime=Wed Dec 22 23:56:19 CST 2021, time=2021-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083363, encodeId=d093108336353, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d25a5516768, createdName=一己怀, createdTime=Wed Dec 22 23:56:17 CST 2021, time=2021-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079886, encodeId=77e310e988655, content=学习了，翻译一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=283c6401883, createdName=ms7000001380639524, createdTime=Tue Dec 14 10:46:57 CST 2021, time=2021-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077143, encodeId=073e10e714306, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=454b5463066, createdName=魏一, createdTime=Sun Dec 05 20:50:16 CST 2021, time=2021-12-05, status=1, ipAttribution=)]
    2021-12-14 ms7000001380639524

    学习了，翻译一下

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2099581, encodeId=1c44209958151, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210420/09716af288084795ba128059da55a818/c3137a18601c4c54bb7d71ac97630870.jpg, createdBy=e9985480565, createdName=ozzy, createdTime=Thu Nov 10 11:21:43 CST 2022, time=2022-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083364, encodeId=ccca108336459, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d25a5516768, createdName=一己怀, createdTime=Wed Dec 22 23:56:19 CST 2021, time=2021-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083363, encodeId=d093108336353, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d25a5516768, createdName=一己怀, createdTime=Wed Dec 22 23:56:17 CST 2021, time=2021-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079886, encodeId=77e310e988655, content=学习了，翻译一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=283c6401883, createdName=ms7000001380639524, createdTime=Tue Dec 14 10:46:57 CST 2021, time=2021-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077143, encodeId=073e10e714306, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=454b5463066, createdName=魏一, createdTime=Sun Dec 05 20:50:16 CST 2021, time=2021-12-05, status=1, ipAttribution=)]
    2021-12-05 魏一

    学习

    0

相关指南

耳穴电刺激治疗抑郁症临床应用专家共识

中国中医科学院针灸研究所 · 2021-06-01

伴非典型特征抑郁症的临床评估与诊治指导建议

中华医学会精神病学分会 · 2021-04-10

伴焦虑痛苦特征抑郁症的临床诊治专家共识

中国神经科学学会(CNS,Chinese Neuroscience Society) · 2021-02-28

2021 加拿大专家共识：难治性抑郁的定义、高危因素及评估

国外精神科相关专家小组（统称） · 2021-02-02

忧郁 / 快感缺失型抑郁症临床评估与诊治指导建议

中国精神科相关专家小组 · 2021-01-30

NICE指南：儿童和青年抑郁症鉴别与治疗

国家卫生和护理研究所（NICE） · 2019-10-01

拓展阅读

2016 CANMAT临床指南：成人抑郁症的管理

加拿大情绪和焦虑治疗网络(CANMAT,Canadian Network for Mood and Anxiety Treatments) · 2016-08-02

2016 ICSI卫生保健指南：抑郁症基层医疗管理（第17版）

临床系统改进协会(ICSI,Institute for Clinical Systems Improvement) · 2016-03-01

2016 EPA指南：慢性抑郁症的心理治疗

欧洲精神病学协会(EPA,European Psychiatric Association) · 2016-03-01

2016 USPSTF建议声明：儿童和青少年抑郁症筛查

美国预防医学工作组(USPSTF,U.S. Preventive Services Task Force) · 2016-02-09

2016 USPSTF建议声明：成人抑郁症筛查  

美国预防医学工作组(USPSTF,U.S. Preventive Services Task Force) · 2016-01-26

2015 AHA科学声明：重度抑郁症和双相情感障碍会导致年轻人加速性动脉粥样硬化和早期心血管疾病  

美国心脏协会(AHA,American Heart Association) · 2015-08-10